Skip to main content
Premium Trial:

Request an Annual Quote

Denator Raises $3.8M

NEW YORK (GenomeWeb News) – Swedish sample preparation firm Denator today announced it raised SEK25.5 million ($3.8 million) in a sixth round of financing.

CEO Olof Sköld said that the fund will "enable us to strengthen our product development and to meet the need [of] our customers and continue our market expansion."

New investor, Novo Seeds, the early stage investment group of Novo A/S, and venture capital firm Almi Invest had a "major" contribution to the financing, Denator said, adding that existing investors also participated.

In conjunction with the financing, Søren Møller, managing investment director at Novo Seeds is joining Denator's board. The investment is Novo Seeds' first in device instrumentation, he said.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.